Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 151-160 of 6864

Page
per page
  1. Cefadroxil (hydrate)
    C3991 Cefadroxil (hydrate)
    Summary: broad-spectrum antibiotic
      insoluble in EtOH; insoluble in H2O; ≥5.8 mg/mL
  2. MDL 100907
    B7605 MDL 100907
    Summary: 5-HT2A receptor antagonist
      ≥122.2 mg/mL
  3. Deferoxamine mesylate
    B6068 Deferoxamine mesylate
     12 Citation
    Summary: iron-chelating agent
      ≥65.7 mg/mL
  4. Teicoplanin A2
    C3940 Teicoplanin A2
    Summary: glycopeptide antibiotic
  5. LY 266097 hydrochloride
    B7583 LY 266097 hydrochloride
    Summary: 5-HT2B receptor antagonist
      Soluble in DMSO
  6. D-Luciferin
    B6040 D-Luciferin
    Summary: cell-permeable chemiluminescent luciferase substrate
      ≥28 mg/mL
  7. Bicyclomycin Benzoate
    C3933 Bicyclomycin Benzoate
    Summary: antibiotic
      Soluble in DMSO
  8. Zotepine
    B7563 Zotepine
    Summary: 5-HT2A receptor and dopamine D2 receptor antagonist
      ≥40.47 mg/mL
  9. Sodium Tauroursodeoxycholate (TUDC)
    B6019 Sodium Tauroursodeoxycholate (TUDC)
    Target: BCPCF efflux
    Summary: water soluble bile salt
      ≥26.1 mg/mL
  10. Cefoperazone (sodium salt)
    C3913 Cefoperazone (sodium salt)
    Summary: cephalosporin antibiotic
      ≥73 mg/mL

Items 151-160 of 6864

Page
per page